Cormorant Asset Management portfolio

67 tracked investments, 11 on the map, $3.1B raised across the mapped portfolio.

Cormorant Asset ManagementCormorant Asset Management67 investments · 11 on the map · $3.1B raised

Also in the portfolio

  • BioAge Labs
  • enGene
  • Terremoto Biosciences
  • BlossomHill Therapeutics
  • Vigil Neuroscience
  • Biomea Fusion
  • Latigo Biotherapeutics
  • Fore Biotherapeutics
  • Tyra Biosciences
  • MOMA Therapeutics
  • nChroma Bio
  • Innovent Biologics
  • Verve Therapeutics
  • BBOT
  • AltruBio
  • Enliven Therapeutics
  • Antares Therapeutics
  • Centessa Pharmaceuticals
  • Zai Lab
  • GondolaBio
  • Stratus Therapeutics
  • Replimune Group
  • Beam Therapeutics
  • Bigfoot Biomedical
  • Ardelyx
  • connectRN
  • Ventus Therapeutics
  • Myra Vision
  • KALA BIO
  • Strata Oncology
  • Cibus
  • ALX Oncology
  • Ambrx
  • Tioga Cardiovascular
  • Pliant Therapeutics
  • Rain Oncology
  • Autolus
  • Pharvaris
  • Kiniksa Pharmaceuticals
  • Atreca
  • FORMA Therapeutics
  • Akouos
  • VYNE Therapeutics
  • Jounce Therapeutics
  • Eidos Therapeutics
  • Gelesis
  • ContraFect
  • Longboard Pharmaceuticals
  • Clearside Biomedical
  • Proteostasis Therapeutics
  • Turning Point Therapeutics
  • Atea Pharmaceuticals
  • Viela Bio
  • MyoKardia

Get matched with startups backed by Cormorant Asset Management

Browse jobs